🇺🇸 FDA
Patent

US 7718658

Quinazolines useful as modulators of ion channels

granted A61PA61P19/02A61P25/06

Quick answer

US patent 7718658 (Quinazolines useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61P, A61P19/02, A61P25/06, A61P25/08, A61P25/22